FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

35598111000001100: MagnEss Gly 39.5mg (1.6mmol) capsules (Essential-Healthcare Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 11-Jul 2018. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
107573101000001114 MagnEss Gly 39.5mg (1.6mmol) capsules (Essential-Healthcare Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
107573201000001119 MagnEss Gly 39.5mg (1.6mmol) capsules (Essential-Healthcare Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
MagnEss Gly 39.5mg (1.6mmol) capsules (Essential-Healthcare Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
MagnEss Gly 39.5mg (1.6mmol) capsules (Essential-Healthcare Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
MagnEss Gly 39.5mg (1.6mmol) capsules (Essential-Healthcare Ltd) Is a Magnesium glycerophosphate (magnesium 39.5mg (1.6mmol)) capsules true Inferred relationship Existential restriction modifier
MagnEss Gly 39.5mg (1.6mmol) capsules (Essential-Healthcare Ltd) Has active ingredient Magnesium glycerophosphate true Inferred relationship Existential restriction modifier
MagnEss Gly 39.5mg (1.6mmol) capsules (Essential-Healthcare Ltd) Has manufactured dose form Capsule false Inferred relationship Existential restriction modifier
MagnEss Gly 39.5mg (1.6mmol) capsules (Essential-Healthcare Ltd) Has basis of strength substance Magnesium true Inferred relationship Existential restriction modifier
MagnEss Gly 39.5mg (1.6mmol) capsules (Essential-Healthcare Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
MagnEss Gly 39.5mg (1.6mmol) capsules (Essential-Healthcare Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
MagnEss Gly 39.5mg (1.6mmol) capsules (Essential-Healthcare Ltd) Has specific active ingredient Magnesium glycerophosphate true Inferred relationship Existential restriction modifier
MagnEss Gly 39.5mg (1.6mmol) capsules (Essential-Healthcare Ltd) Has dispensed dose form Capsule true Inferred relationship Existential restriction modifier
MagnEss Gly 39.5mg (1.6mmol) capsules (Essential-Healthcare Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Magnesium true Inferred relationship Existential restriction modifier
MagnEss Gly 39.5mg (1.6mmol) capsules (Essential-Healthcare Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
MagnEss Gly 39.5mg (1.6mmol) capsules (Essential-Healthcare Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
MagnEss Gly 39.5mg (1.6mmol) capsules (Essential-Healthcare Ltd) Is a MagnEss Gly true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
MagnEss Gly 39.5mg (1.6mmol) capsules (Essential-Healthcare Ltd) 50 capsule Has AMP True MagnEss Gly 39.5mg (1.6mmol) capsules (Essential-Healthcare Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start